IT1064728B - Acido 1 idrossi 3 amminoalcan 1,1 difosfonico - Google Patents

Acido 1 idrossi 3 amminoalcan 1,1 difosfonico

Info

Publication number
IT1064728B
IT1064728B IT25717/76A IT2571776A IT1064728B IT 1064728 B IT1064728 B IT 1064728B IT 25717/76 A IT25717/76 A IT 25717/76A IT 2571776 A IT2571776 A IT 2571776A IT 1064728 B IT1064728 B IT 1064728B
Authority
IT
Italy
Prior art keywords
alkan
diphosphonic
hydroxy
amino
acid
Prior art date
Application number
IT25717/76A
Other languages
English (en)
Original Assignee
Henkel & Cie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel & Cie Gmbh filed Critical Henkel & Cie Gmbh
Application granted granted Critical
Publication of IT1064728B publication Critical patent/IT1064728B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00—Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • C02F5/10—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
    • C02F5/14—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/36—Organic compounds containing phosphorus
    • C11D3/364—Organic compounds containing phosphorus containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23F—NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D OR C22F OR CLASS C25
    • C23F11/00—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent
    • C23F11/08—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent in other liquids
    • C23F11/10—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent in other liquids using organic inhibitors
    • C23F11/167—Phosphorus-containing compounds
    • C23F11/1676—Phosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Metallurgy (AREA)
  • Diabetes (AREA)
  • Water Supply & Treatment (AREA)
  • Birds (AREA)
  • Hydrology & Water Resources (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental & Geological Engineering (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT25717/76A 1975-08-01 1976-07-27 Acido 1 idrossi 3 amminoalcan 1,1 difosfonico IT1064728B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2534391A DE2534391C2 (de) 1975-08-01 1975-08-01 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren

Publications (1)

Publication Number Publication Date
IT1064728B true IT1064728B (it) 1985-02-25

Family

ID=5952992

Family Applications (1)

Application Number Title Priority Date Filing Date
IT25717/76A IT1064728B (it) 1975-08-01 1976-07-27 Acido 1 idrossi 3 amminoalcan 1,1 difosfonico

Country Status (10)

Country Link
US (1) US4054598A (it)
JP (1) JPS5925798B2 (it)
AT (2) AT349642B (it)
BE (1) BE844649A (it)
CH (2) CH599234A5 (it)
DE (1) DE2534391C2 (it)
FR (1) FR2319646A1 (it)
GB (1) GB1540238A (it)
IT (1) IT1064728B (it)
NL (1) NL7607703A (it)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
US4029696A (en) * 1976-04-09 1977-06-14 Benckiser-Knapsack Gmbh N-hydroxy alkane amino alkane diphosphonic acids, process of producing same, and compositions for and method of using same
US4208401A (en) * 1977-08-19 1980-06-17 Colgate-Palmolive Company Quaternary ammonium alkylene diphosphonate anti-calculus agents
DE2745084A1 (de) * 1977-10-07 1979-04-12 Henkel Kgaa Diphosphonsaeuren
DE2745083C2 (de) * 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
US4234511A (en) * 1979-07-26 1980-11-18 Buckman Laboratories, Inc. Dialkylamino-N,N-bis(phosphonoalkylene)alkylamines and use in aqueous systems as precipitation and corrosion inhibitors
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
ATE26071T1 (de) 1982-06-10 1987-04-15 Mallinckrodt Inc Roentgen-sichtbarmachungsmittel.
DE3334211A1 (de) * 1983-09-22 1985-04-04 Henkel KGaA, 4000 Düsseldorf Dihydroxyalkandiphosphonsaeuren
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
DE3434667A1 (de) * 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
IT1196315B (it) * 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3540150A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3724653A1 (de) * 1987-07-25 1989-02-02 Henkel Kgaa Olefinische diphosphonsaeuren, verfahren zu ihrer herstellung und ihre verwendung als thresholder sowie komplexierend wirkende, olefinische diphosphonsaeuren enthaltende zusammensetzungen
DE3724654A1 (de) * 1987-07-25 1989-02-02 Henkel Kgaa Hydroxyacetonitrildiphosphonsaeure, verfahren zu ihrer herstellung und ihre verwendung
US5110807A (en) * 1988-12-01 1992-05-05 Ciba-Geigy Corporation Araliphatylaminoalkanediphosphonic acids
US5190930A (en) * 1987-12-11 1993-03-02 Ciba-Geigy Corporation Araliphatylaminoalkanediphosphonic acids
DE3812693A1 (de) * 1988-03-19 1989-09-28 Reckitt Gmbh Reinigungstablette fuer zahnprothesen
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
US5154843A (en) * 1989-02-08 1992-10-13 The Lubrizol Corporation Hydroxyalkane phosphonic acids and derivatives thereof and lubricants containing the same
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
US5227506A (en) * 1989-09-06 1993-07-13 Merck & Co., Inc. Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
DE69023844T2 (de) * 1989-09-06 1996-06-20 Merck & Co Inc Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5158763A (en) * 1990-10-09 1992-10-27 Colgate-Palmolive Company Non-staining anti-bacterial oral composition
US5318772A (en) * 1991-12-10 1994-06-07 The Dow Chemical Company Oral compositions for inhibiting calculus formation
NZ252587A (en) * 1992-05-29 1997-02-24 Procter & Gamble Pharma Phosphonate compounds; quaternary nitrogen containing compounds and pharmaceutical compositions containing them
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
EP0753523A1 (en) 1995-07-10 1997-01-15 Gador S.A. Amino-substituted bisphosphonic acids
AR024462A1 (es) 1999-07-01 2002-10-02 Merck & Co Inc Tabletas farmaceuticas
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US7595109B2 (en) * 2001-04-12 2009-09-29 Eestor, Inc. Electrical-energy-storage unit (EESU) utilizing ceramic and integrated-circuit technologies for replacement of electrochemical batteries
US7914755B2 (en) * 2001-04-12 2011-03-29 Eestor, Inc. Method of preparing ceramic powders using chelate precursors
US7729811B1 (en) 2001-04-12 2010-06-01 Eestor, Inc. Systems and methods for utility grid power averaging, long term uninterruptible power supply, power line isolation from noise and transients and intelligent power transfer on demand
MXPA04006027A (es) * 2001-12-21 2004-09-27 Procter & Gamble Metodo para el tratamiento de trastornos de los huesos.
ITMI20020908A1 (it) * 2002-04-29 2003-10-29 Chemi Spa Processo di preparazione di sodio alendronato
EP1880744B1 (en) * 2002-05-10 2015-01-21 F.Hoffmann-La Roche Ag Bisphosphonic acids for the treatment and prevention of osteoporosis
JP4485117B2 (ja) * 2002-06-27 2010-06-16 日東電工株式会社 保護剥離用フィルム
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
ES2530791T3 (es) 2002-12-20 2015-03-05 Hoffmann La Roche Formulación de ibandronato de altas dosis
US20040206932A1 (en) * 2002-12-30 2004-10-21 Abuelyaman Ahmed S. Compositions including polymerizable bisphosphonic acids and methods
CA2535556C (en) * 2003-08-12 2014-01-07 3M Innovative Properties Company Self-etching dental compositions and methods
JP5214242B2 (ja) 2004-07-08 2013-06-19 スリーエム イノベイティブ プロパティズ カンパニー 歯科用の方法、組成物、および酸感受性色素を含むキット
CN101035499B (zh) 2004-08-11 2012-09-05 3M创新有限公司 包括多种酸性化合物的自粘合组合物
US20060104931A1 (en) * 2004-11-12 2006-05-18 Takeshi Fukutome Cosmetic treatment article comprising substrate and gel composition
US7648687B1 (en) * 2006-06-15 2010-01-19 Eestor, Inc. Method of purifying barium nitrate aqueous solution
US8178712B2 (en) * 2006-06-23 2012-05-15 Cipla Ltd. Process for the synthesis of Ibandronate sodium
US20110053758A1 (en) * 2009-02-27 2011-03-03 Eestor, Inc. Reaction tube and hydrothermal processing for the wet chemical co-precipitation of oxide powders
US7993611B2 (en) * 2006-08-02 2011-08-09 Eestor, Inc. Method of preparing ceramic powders using ammonium oxalate
US8853116B2 (en) * 2006-08-02 2014-10-07 Eestor, Inc. Method of preparing ceramic powders
US8145362B2 (en) * 2006-08-04 2012-03-27 Eestor, Inc. Utility grid power averaging and conditioning
WO2008076739A2 (en) * 2006-12-13 2008-06-26 3M Innovative Properties Company Methods of using a dental composition having an acidic component and a photobleachable dye
SI2144919T1 (sl) * 2007-04-11 2016-02-29 F. Hoffmann-La Roche Ag Večstopenjska sinteza ibandronata
WO2012134424A2 (en) * 2010-01-20 2012-10-04 Eestor, Inc. Purification of barium ion source
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
PL407922A1 (pl) 2014-04-16 2015-10-26 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Nowe bisfosfoniany i ich zastosowanie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1002355C2 (de) * 1954-05-03 1957-07-25 Thomae Gmbh Dr K Verfahren zur Herstellung von ª‡-prim.-Amino-diphosphonsaeuren und deren Estern
FR96342E (it) * 1967-12-09 1972-06-16
US3705191A (en) * 1970-04-13 1972-12-05 Monsanto Co Substituted ethane diphosphonic acids and salts and esters thereof
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper

Also Published As

Publication number Publication date
JPS5219628A (en) 1977-02-15
DE2534391C2 (de) 1983-01-13
AT350161B (de) 1979-05-10
ATA563376A (de) 1978-09-15
JPS5925798B2 (ja) 1984-06-21
BE844649A (fr) 1977-01-31
ATA563176A (de) 1978-10-15
GB1540238A (en) 1979-02-07
AT349642B (de) 1979-04-10
DE2534391A1 (de) 1977-02-17
CH620359A5 (it) 1980-11-28
US4054598A (en) 1977-10-18
NL7607703A (nl) 1977-02-03
CH599234A5 (it) 1978-05-31
FR2319646A1 (fr) 1977-02-25
FR2319646B1 (it) 1978-05-05

Similar Documents

Publication Publication Date Title
IT1064728B (it) Acido 1 idrossi 3 amminoalcan 1,1 difosfonico
DK579875A (da) Aminosyrepreparater
SE7612365L (sv) L-fenyl-2-oxo-pyrrolidin-4-karbonsyraderivat
SE7608840L (sv) Prostansyraderivat
AU1934876A (en) Hydroxybenzylmalonic acid derivatives
DK412976A (da) Udleveringssystem
NZ182908A (en) 2-tertiaryaminoindol-3-ylcarboxylic acid derivatives
AR208988A1 (es) Conectador mejorado
FR2297633A1 (fr) Po
NL7613659A (nl) Hydroxybenzylmalonzuurderivaten.
IT1064733B (it) Acido 1.3 diamminoalcan 1.1 difosfonico
JPS51133245A (en) Nnarylanthranyl acid
NL7609137A (nl) Fenoxyalkylcarbonzuurderivaten.
JPS51125361A (en) Phosphinic acid or their salts
FR2305977A1 (fr) Solution parenterale d'amino-acides
FR2314732A1 (fr) Solution d'iodophore
SE7601566L (sv) Prostansyraderivat
AU1522876A (en) D1-and 8r-9-fluoro-prostadianoic acid
BR7603502A (pt) Aperfeicoamentos em conectores
SE416692B (sv) Tillslutningselement for en kondensator
AU2051676A (en) 7-acylamido-3-cephem-4-carboxylic acid
ZA764209B (en) Azanaphthaleneacetic acid derivatives
IE43457L (en) 1-deoxyribofuranuronic acid derivatives
SE7604287L (sv) Deoxiklavulansyra
SE429256B (sv) Anslutningselement for festdon